
Patrick Soon-Shiong
South African and American doctor (born 1952)

South African and American doctor (born 1952)
Patrick Soon-Shiong (Chinese: 黄馨祥; pinyin: Huáng Xīnxiáng; born July 29, 1952) is a South African and American businessman, researcher and surgeon who invented Abraxane, a drug used for lung, breast, and pancreatic cancer. He has been the owner and executive chairman of the Los Angeles Times since 2018. Soon-Shiong received FDA approval for a new class of immunotherapy drug called Anktiva in non-muscle invasive bladder cancer in 2024. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. He is currently Executive Chairman, Global Chief Medical & Technology Officer at ImmunityBio. Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers...
Read on Wikipedia · Image NHS Confederation, CC BY 2.0
Open boosters, collect cards and trade them. Free to play.
Play for free